News
Founder & CEO of Royalty Pharma. Quest Diagnostics continues to retain royalty rights to other clinical indications that result from Celera's drug assets, including programs that target histone ...
A notable holdout: pharmaceutical company executives who ... Black Caucus has been a primary target of the industry in its quest for new Democratic friends. This election cycle, though, is the ...
On Thursday, Connecticut-based pharmaceutical company Biohaven nabbed an FDA approval for Nurtec, the company’s migraine medication. Nurtec was approved in March of 2020 to treat acute migraines ...
Founder & CEO of Royalty Pharma. Quest Diagnostics continues to retain royalty rights to other clinical indications that result from Celera's drug assets, including programs that target histone ...
("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the formation of an international clinical advisory panel ...
Since LEAP’s launch, Ori has worked with five different partners, including a “big pharma partner ... Foster pointed out. Ori Biotech isn’t alone in its quest to automate cell and ...
GlaxoSmithKline plc ("GSK") announces that it has sold its entire holding of 30,755,151 shares of common stock in Quest Diagnostics ... world's leading research-based pharmaceutical and healthcare ...
That wide approval indicates long-term bullishness in this biotech stock, even if short-term turbulence makes actively trading shares a volatile proposition. Recursion Pharmaceuticals (RXRX ...
Pharmalittle: We’re reading about Trump team moving on pharma tariffs, PBMs under pressure, and more
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry ... is maple bourbon — and continue our quest for items of interest.
it reduces the incentives for Big Pharma and start-up biotech firms alike to invest in drug research and development. And those costs are massive. The Washington Post reported Tuesday that "the ...
June 13 (Reuters) - Biotec Pharmacon ASA : * Received the decision by the arbitration court related to the Company's nutrition business brought up by company Sana Pharma AS Sign up here.
Americans live longer than ever, and a handful of biotech stocks stand at the forefront of longevity’s future. Many misconceive anti-aging stocks as peddling some magic pill that inexplicably ma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results